# Neuropathic Pain Severity Is Associated With Opioid Use in Adults With Traumatic Spinal Cord Injury: A Spinal Cord Injury Model System Study.

> **Author:** Benjamin Caplan, MD (ABFM Board Certified, MA Lic. #240562, NPI: 1962722637)
> **Publisher:** CED Clinic (https://cedclinic.com)
> **Canonical URL:** https://cedclinic.com/neuropathic-pain-spinal-cord-injury-opioid-use-study/
> **Published:** 2026-04-28T02:03:46-04:00 | **Last Modified / Clinically Audited:** 2026-09-28T10:09:26-04:00
> **Clinical Summary:** New research reveals how neuropathic pain severity drives opioid use in spinal cord injury patients, while employment reduces opioid dependence risk by 33%.

---

CED Clinical Relevance  #64Notable Clinical Interest
Evidence Brief | CED ClinicHigher [neuropathic pain](https://cedclinic.com/cannabis-for-pain-relief/) severity predicts opioid use in adults with spinal cord injury, while employment correlates with reduced opioid utilization.
[Neuropathic Pain](https://cedclinic.com/cannabis-for-pain-relief/)Spinal Cord InjuryOpioidsCannabis[Pain Management](https://cedclinic.com/cbd-cbg-topicals-for-eczema/)

Higher neuropathic pain severity predicts opioid use in adults with spinal cord injury, while employment correlates with reduced opioid utilization.

What This Study Teaches Us

This study demonstrates that neuropathic pain severity drives opioid [prescribing patterns](https://cedclinic.com/medical-cannabis-prescribing-patterns-uk-doctors/) in spinal cord injury populations, consistent with clinical intuition. The employment correlation suggests either that functional capacity reduces pain medication dependence or that opioid-free patients maintain better vocational outcomes.

Why This Matters
Spinal cord injury patients face complex neuropathic pain that often resists conventional treatment, making opioid decisions particularly challenging. Understanding predictors of opioid use helps clinicians anticipate medication needs and potentially identify patients who might benefit from alternative [pain management](https://cedclinic.com/cbd-cbg-topicals-for-eczema/) strategies.

Study Snapshot

Study Type
Cross-sectional observational study

Population
283 adults with spinal cord injury from 6 SCI Model System centers

Intervention
Assessment of pain severity and medication use patterns

Comparator
Opioid users (n=104) versus non-users (n=179)

Primary Outcome
Association between neuropathic pain severity and active opioid use

Key Finding
Employment associated with 33% reduction in opioid use; opioid users more likely to use anti-epileptics and cannabis combinations

Journal
Topics in Spinal Cord Injury Rehabilitation

Year
2024

Clinical Bottom Line
Neuropathic pain severity remains a primary driver of opioid use in spinal cord injury patients, while employment status may serve as a protective factor. The association between opioid use and combination therapies including cannabis suggests patients are seeking multimodal pain relief.

What This Paper Does Not Show
This cross-sectional design cannot establish whether pain severity causes opioid use or whether opioid use influences pain perception and functional outcomes. The study does not demonstrate efficacy or safety of any particular pain management approach.

Where This Paper Deserves Skepticism
The employment-opioid relationship could reflect reverse causation, selection bias, or unmeasured confounders like injury severity or socioeconomic status. Self-reported pain and medication use data may introduce recall or social desirability bias.

Dr. Caplan's Take
This confirms what I see clinically – SCI patients with severe neuropathic pain often require opioids despite our best efforts with other modalities. The employment correlation is intriguing but needs prospective validation before drawing causal conclusions about work as pain medicine.

What a Careful Reader Should Take Away

Neuropathic pain severity appropriately predicts opioid use in SCI patients, validating current [clinical practice](https://cedclinic.com/cannabis-reproductive-health-women-clinical-evidence/) patterns. The employment association warrants further investigation but should not influence individual prescribing decisions without better understanding of causality.

Join the Conversation

Have a question about how this applies to your situation? [Ask Dr. Caplan →](https://benjamincaplan.com/ask-dr-caplan)

Want to discuss this topic with other patients and caregivers? [Join the forum discussion →](https://cedclinic.com/interact/discussion-forums/forum/cannabis-industry/)

Have thoughts on this? Share it:

[X Share on X](https://twitter.com/intent/tweet?text=Just%20read%20this%20on%20CEDclinic.com%3A%20Neuropathic%20Pain%20Severity%20Is%20Associated%20With%20Opioid%20Use%20in%20Adults%20With%20Traumatic%20Spinal%20Cord%20Injury%3A...%20%40drcaplan&url=https%3A%2F%2Fcedclinic.com%2Fneuropathic-pain-spinal-cord-injury-opioid-use-study%2F)[in Share on LinkedIn](https://www.linkedin.com/sharing/share-offsite/?url=https%3A%2F%2Fcedclinic.com%2Fneuropathic-pain-spinal-cord-injury-opioid-use-study%2F)[🦅 Share on BlueSky](https://bsky.app/intent/compose?text=Just%20read%20this%3A%20Neuropathic%20Pain%20Severity%20Is%20Associated%20With%20Opioid%20Use%20in%20Adults%20With%20Traumatic%20Spinal%20Cord%20Injury%3A...%20via%20%40drcaplan.bsky.social%20https%3A%2F%2Fcedclinic.com%2Fneuropathic-pain-spinal-cord-injury-opioid-use-study%2F)[📷 Follow on Instagram](https://www.instagram.com/drbenjamincaplan)[📝 Read more on Substack](https://doctorapprovedcannabis.substack.com/)[🔔 Subscribe via RSS](https://cedclinic.com/feed/)

Table of Contents

- [FAQ](#FAQ)[What factors predict opioid use for neuropathic pain in spinal cord injury patients?](#What_factors_predict_opioid_use_for_neuropathic_pain_in_spinal_cord_injury_patients)
- [How common is opioid use among spinal cord injury patients with neuropathic pain?](#How_common_is_opioid_use_among_spinal_cord_injury_patients_with_neuropathic_pain)
- [What other medications do spinal cord injury patients commonly use alongside or instead of opioids?](#What_other_medications_do_spinal_cord_injury_patients_commonly_use_alongside_or_instead_of_opioids)
- [Does employment status affect pain medication use in spinal cord injury patients?](#Does_employment_status_affect_pain_medication_use_in_spinal_cord_injury_patients)
- [What role does cannabis play in neuropathic pain management for spinal cord injury patients?](#What_role_does_cannabis_play_in_neuropathic_pain_management_for_spinal_cord_injury_patients)
- [Related](#Related)

## FAQ

#### What factors predict opioid use for neuropathic pain in spinal cord injury patients?

Higher neuropathic pain severity is the primary predictor of opioid use in adults with spinal cord injury. Employment status is protective, with employed individuals showing a 33% reduction in opioid use compared to unemployed patients.

#### How common is opioid use among spinal cord injury patients with neuropathic pain?

In this study of 283 adults with spinal cord injury, 104 participants (37%) were current opioid users while 179 (63%) were non-users. This suggests that over one-third of SCI patients use opioids for neuropathic pain management.

#### What other medications do spinal cord injury patients commonly use alongside or instead of opioids?

Opioid users were more likely to use anti-epileptic medications, either alone or in combination with cannabis. This suggests that multimodal pain management approaches are common in this population.

#### Does employment status affect pain medication use in spinal cord injury patients?

Yes, employment appears to be protective against opioid use. Employed individuals with spinal cord injury had a 33% lower likelihood of using opioids compared to unemployed patients, independent of other clinical factors.

#### What role does cannabis play in neuropathic pain management for spinal cord injury patients?

The study found that cannabis is often used in combination with anti-epileptic medications among opioid users. This suggests cannabis may serve as part of a multimodal approach to neuropathic pain management in this population.

 [https://cedclinic.com/contact/](https://cedclinic.com/contact/)
 

Physician-Led, Whole-Person Care
A doctor who takes the time to truly understand you.
Personal care that starts with listening and is guided by experience and ingenuity.

Health, Longevity, Wellness
One-on-One Cannabis Guidance
Metabolic Balance

 [Leave a Message](https://cedclinic.com/contact/)
 [Metabolic Care](https://cedclinic.com/metabolic/metabolic-how-it-works/)
 [Medical Consulting](https://cedclinic.com/book/)
 [Cannabis Care](https://cedclinic.com/book/)
 

 [https://cedclinic.com/contact/](https://cedclinic.com/contact/)
 

 

### Related

---

### Verification & Medical Governance

- **Lead Clinical Author:** Benjamin Caplan, MD
- **Credentials:** Board Certified in Family Medicine (ABFM), Former CMO Canna Care Docs (250,000+ patients supervised), Founder & CMO CED Clinic & CED Foundation, Author of *The Doctor-Approved Cannabis Handbook* (Penguin Random House).
- **Clinical Scale:** 350,000+ lifetime evaluations overseen; 81,008-patient Real-World Evidence Registry (`~/.ced_rwe_vault.db`); 125,000+ peer-reviewed study literature observatory (`http://localhost:8768/api/explorer/terminal`).
- **License Verification:** Commonwealth of Massachusetts License #240562 (https://checkahealthlicense.mass.gov/).
- **NPI Registry:** 1962722637 (https://npiregistry.cms.hhs.gov/provider-view/1962722637).
- **Ethics & Data Privacy:** Clinical registry observations adhere strictly to HIPAA Safe Harbor de-identification (45 CFR § 164.514(b)) and criteria for secondary research exemption under 45 CFR § 46.104(d)(4).
